Eur Rev Med Pharmacol Sci 2023; 27 (10): 4326-4326

DOI: 10.26355/eurrev_202305_32435

L. Zhang, B. Liu, Q.-H. Deng, J.-X. Li

Department of Urology, Jingmen No. 2 People’s Hospital, Jingmen, China

The article “LncRNA BRE-AS1 acts as a tumor suppressor factor in bladder cancer via mediating STAT3”, by L. Zhang, B. Liu, Q.-H. Deng, J.-X. Li, published in Eur Rev Med Pharmacol Sci 2020; 24 (10): 5320-5328–DOI: 10.26355/eurrev_202005_21314–PMID: 32495865 has been retracted by the Editor in Chief for the following reasons:

This paper has been questioned on PubPeer (https://pubpeer.com/publications/F4A75D571A58C9005B703B2B8C4A8E). In particular, concerns were raised about Figures 2D and 5A as the figures result to overlap with previously published papers. The paper has been identified with the “The Clear Skies Papermill Alarm”.

The Editorial Office has contacted the corresponding author of the article to provide a reply to the comments on PubPeer and the raw data. Still, the journal has yet to receive a reply. Therefore, considering the comments released on PubPeer and the lack of response from authors, the Editor in Chief no longer relies on the data presented and decided to withdraw the manuscript.

The Publisher apologizes for any inconvenience this may cause.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License

L. Zhang, B. Liu, Q.-H. Deng, J.-X. Li
Retraction Note: LncRNA BRE-AS1 acts as a tumor suppressor factor in bladder cancer via mediating STAT3

Eur Rev Med Pharmacol Sci
Year: 2023
Vol. 27 - N. 10
Pages: 4326-4326
DOI: 10.26355/eurrev_202305_32435

Tag: Retraction notice